Modulation of Molecular Fingerprinting in Pediatric Sepsis
Recruiting now
Conditions studied: Systemic Inflammatory Response Syndrome
In brief
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Key facts
- Study ID
- NCT02055105
- Run by
- Phoenix Children's Hospital
- People needed
- 50
- Starts
- 2014-03-01
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2025-11-12
Who can join
Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 1 through 18 years
- Patients admitted to the PICU with concerns for sepsis or those developing sepsis during their admission to the hospital.
- Patients must be enrolled int he study from arrival time tot he ED up to 24 hours from the time of initiation of antibiotic therapy for treatment of sepsis or septic shock.
- Signed informed consent.
You may not qualify if…
- Patients <1 year of age and greater than 18 years of age.
Where it is running
- Phoenix Children's Hospital — Phoenix, Arizona, United States (enrolling)
- Phoenix Children's Hospital — Phoenix, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.